Abstract

Next-Generation Labelling

Jürgen Schmied, CEO and Founder, GATTAquant

DNA nanotechnology currently revolutionizes many areas of science and technology. Our mission is to bring this technology into diagnostics in the form of a truly versatile and customizable detection system.  It can be applied to immunoassays just as well as nucleic acid testing. Our technology allows ultra-sensitive detection down to the single-molecule level without additional signal amplification steps.  This presentation contains truly novel approaches to tackle common difficulties of (fluorescence) detection. A new type of super-bright and versatile label is discussed along with strategies how to attach the label to its probe. Furthermore, massive multiplexing and simultaneous detection of nucleic acids and proteins will be presented.